Immediate Impact

1 by Nobel laureates 9 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
2024 Standout
2 intermediate papers

Works of Melek Ergin being referenced

PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.
2013
Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas
2008

Author Peers

Author Last Decade Papers Cites
Melek Ergin 502 439 335 80 1.4k
Ryuichi Kamiyama 542 433 378 74 1.8k
Batia Avni 405 433 237 65 1.3k
T Hotta 389 546 447 128 1.8k
John L. Reagan 390 558 313 102 1.4k
Chi Young Ok 373 569 518 85 1.5k
Sheila N.J. Sait 505 325 174 72 1.2k
Katsuji Shinagawa 585 536 343 107 1.9k
Jae‐Sook Ahn 362 438 367 127 1.4k
W. Lange 508 803 271 59 1.9k
João L. Ascensão 334 524 291 64 1.8k

All Works

Loading papers...

Rankless by CCL
2026